As we just dealt with improving male sexual response, it’s now the ladies’ turn (and we’ll pass up the obvious joke opportunities…). You may have heard that an FDA panel has recommended approval of the drug Flibanserin, popularly known as Female Viagra. Which sounds great. Except, as as this article from Vox explains, the drug offers very minimal results (one additional “sexually satisfying event” per month) with a pretty high chance of side effects (low blood pressure, dizziness, fainting). Critics call the whole thing a marketing ploy by Big Pharma, just looking for a new product to sell.
Unlike Viagra, which works by increasing blood flow to a man’s reproductive organs, Flibanserin creates changes in a woman’s serotonin and other brain chemicals. It was originally studied as an anti-depressant before being repurposed as a libido pill. The drug’s maker sponsored a pubic relations campaign called “Even the Score” which cited the high number of male libido drugs available, compared to none for women.
But if this is the best they can come up with for women, I don’t think it’s going to work. What do you think?